About Mivax Therapeutics
Mivax Therapeutics is a private company based in San Francisco, California, incorporated in 2024 in Delaware. It has reported $202,500 raised in one offering on Form D since May 2025. Its chief executive is Pragyesh Dhungel.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 17, 2025 | May 1, 2025amended Jan 23, 2026 | $202,500of $500K target | 21 | $9,643 | EquityRule 506(b) | Form D/A ↗3 earlier filings |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Mivax Therapeutics's Form D filed Jan 23, 2026.
PD
Pragyesh Dhungel
Chief Executive Officer and Treasurer
VD
Viraj Deshpande
President and Secretary